▶ 調査レポート

世界の薬物乱用試験市場

• 英文タイトル:Drug Abuse Testing Market - Growth, Trends, and Forecast (2019 - 2024)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の薬物乱用試験市場 / Drug Abuse Testing Market - Growth, Trends, and Forecast (2019 - 2024) / C-MOR-100153資料のイメージです。• レポートコード:C-MOR-100153
• 出版社/出版日:Mordor Intelligence / 2019年9月
• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Multi User¥703,000 (USD4,750)▷ お問い合わせ
  Site License¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、薬物乱用試験の世界市場について調査・分析し、薬物乱用試験の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。

Market Overview
The drug abuse testing market will show rapid growth due to the increasing demand for drug abuse treatment, stringent law mandating alcohol and drug testing and rising drug-related mortality and increasing government initiative.

The use of drugs is found giving rise to a lot of illegal activities that consume a lot of resources of a country. These aspects have driven the governments of developed and emerging nations to take legal action against addicts and abusers. Therefore the developed countries such as the United States has stringent laws for drug abuse and have mandated the alcohol and drug testing. For the sake of limiting violence or accidents, drug and alcohol testing on the streets is becoming very common in developing as well as developed countries, which is, in turn, helping the growth of the overall market. Thus a growing trend witnessed in the drug abuse testing market is that leading players are enhancing their product portfolio through the addition of products and updating of software with new substances for drug abuse testing, in order to maintain their competency and market share.

Identifying drug testing strategies are also necessary, as they may lead to the adoption of drugs testing kits and devices, and thus, boost the market growth. Other factors that are expected to affect the growth of this market positively, include increasing demand for drug addiction treatment, rising drug-related mortality, and growing government initiative.

This market is also currently growing due to technological advancements, increased sensitivity, reduced times required for testing, and facilitated detection of newly developed designer drugs.

Scope of the Report

As per the scope of the report, drugs of abuse testing is found to be a clinical screening procedure to detect one or more illegal substances like drug, chemical, or plant product that is addicted to the patient. This clinical screening procedure is performed on the patient’s urine, saliva, blood, hair or sweat. Today’s modern lifestyle is pushing the adults towards drugs of abuse testing, and to rescue the adults from DOA the government is promoting the DOA testing.

Key Market Trends

Urine is Anticipated to be the Dominant Segment in Sample Type During the Forecast Period

Drug testing by urine analysis has been suggested and in many cases implemented for workplace drug abuse, as well as in the criminal justice cases, etc. There are setup of many laboratories that were established to perform urinalysis associated with methadone treatment that has had to greatly expand their capacities. In the recent years, many new laboratories have sprung up to meet the demands for drug assays and clinical laboratories associated with medical centers, under economic pressures in recent years, that has begun to venture into drug testing. Therefore, the urine analysis segment of the market is expected to gain traction in the near future.

In addition, the technological developments in drug abuse testing and the growing demand for drug tests have led to the increasing use of urine analysis for drug abuse.

North America Region Holds the Largest Market Share of Drug Abuse Testing Market

North America has been accounted for the largest share in the drug abuse testing market, globally. Drug abuse is a serious problem that can lead to legal, financial, and health problems and the North America region is currently facing the same problem. Therefore, various initiatives are being implemented by the United States government to monitor the symptoms and to determine whether a population is abusing drugs. For instance, Patients and Communities Act of 2018 is the latest law implemented by the country for counter-acting drug abuse.

There is also a high contribution due to the adaptation of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, large scale drug trafficking, that is being responsible for the growth of the market.

Competitive Landscape

The leading players through acquisitions are attaining competency and larger market share in the global drug abuse testing industry. The major player in the DoA testing market includes Danaher Corporation, Siemens AG, Drägerwerk AG & Co. KGaA, bioMérieux S.A., F. Hoffmann-La Roche AG, Quest Diagnostics Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, ThermoFisher Scientific Inc., Randox Laboratories Ltd.

Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand For Drug Abuse Treatment
4.2.2 Stringent Law Mandating Alcohol and Drug Testing
4.2.3 Rising Drug Related Mortality and Increasing Government Initiative
4.3 Market Restraints
4.3.1 Perception of Drug Abuse Testing as a Violation of Rights
4.3.2 Lack of Awareness Regarding the Availability of Advanced Drug Testing Devices
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Analyzers
5.1.1.1 Immunoassays Analyzers
5.1.1.2 Chromatographic Devices
5.1.1.3 Breath Analyzers
5.1.2 Rapid Testing Devices
5.1.2.1 Urine Testing Devices
5.1.2.2 Oral Fluid Testing Devices
5.1.3 Consumables
5.1.3.1 Fluid Collection Devices
5.1.3.2 Other Consumables
5.2 By Sample Type
5.2.1 Saliva
5.2.2 Urine
5.2.3 Blood
5.2.4 Others
5.3 By End User
5.3.1 Hospitals
5.3.2 Diagnostic Laboratories
5.3.3 Forensic Laboratories
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alere Inc. (Abbott Laboratories)
6.1.2 Danaher Corporation (Beckman Coulter, Inc.).
6.1.3 Lab Corps of America Holdings
6.1.4 Dragerwerk AG & Co. KGaA
6.1.5 Quest Diagnostics Inc.
6.1.6 Randox Testing Services
6.1.7 United States Drug Testing Laboratories Inc. (USDTL)
6.1.8 Thermo Fisher Scientific Inc.
6.1.9 Siemens Healthineers
6.1.10 F. Hoffmann-La Roche Ltd.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS